000 | 01915 a2200553 4500 | ||
---|---|---|---|
005 | 20250517162608.0 | ||
264 | 0 | _c20180226 | |
008 | 201802s 0 0 eng d | ||
022 | _a2235-2988 | ||
024 | 7 |
_a10.3389/fcimb.2017.00269 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMa, Hong-Wei | |
245 | 0 | 0 |
_aIn-Cell Western Assays to Evaluate Hantaan Virus Replication as a Novel Approach to Screen Antiviral Molecules and Detect Neutralizing Antibody Titers. _h[electronic resource] |
260 |
_bFrontiers in cellular and infection microbiology _c2017 |
||
300 |
_a269 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aA549 Cells |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
650 | 0 | 4 |
_aAntibodies, Neutralizing _ximmunology |
650 | 0 | 4 | _aAntibodies, Viral |
650 | 0 | 4 |
_aAntiviral Agents _xisolation & purification |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 |
_aDEAD-box RNA Helicases _xpharmacology |
650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 |
_aHantaan virus _xdrug effects |
650 | 0 | 4 |
_aHemorrhagic Fever with Renal Syndrome _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Humoral |
650 | 0 | 4 |
_aInterferons _xpharmacology |
650 | 0 | 4 | _aVero Cells |
650 | 0 | 4 |
_aViral Proteins _xmetabolism |
650 | 0 | 4 | _aViral Vaccines |
650 | 0 | 4 |
_aVirus Replication _ximmunology |
700 | 1 | _aYe, Wei | |
700 | 1 | _aChen, He-Song | |
700 | 1 | _aNie, Tie-Jian | |
700 | 1 | _aCheng, Lin-Feng | |
700 | 1 | _aZhang, Liang | |
700 | 1 | _aHan, Pei-Jun | |
700 | 1 | _aWu, Xing-An | |
700 | 1 | _aXu, Zhi-Kai | |
700 | 1 | _aLei, Ying-Feng | |
700 | 1 | _aZhang, Fang-Lin | |
773 | 0 |
_tFrontiers in cellular and infection microbiology _gvol. 7 _gp. 269 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3389/fcimb.2017.00269 _zAvailable from publisher's website |
999 |
_c27337719 _d27337719 |